Drugs / Administration of L-TC
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT06476704 | Jul 2026 → Oct 2028 expected | sarcoma | Centre Paul Strauss | Not yet recruiting | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Administration of L-TC | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06476704 ↗ |
| Route | Intravenous | “administered as intravenous infusion over 90 minutes” NCT06476704 ↗ |